Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis

Area of Science:

• Genetics
• Obstetrics
• Molecular Biology

Background:

• Preeclampsia is a pregnancy complication with complex etiology.
• Genetic factors are implicated, but associations with specific gene polymorphisms remain controversial.

Purpose of the Study:

• To systematically evaluate the association between polymorphisms in endothelial nitric oxide synthase (eNOS), angiotensinogen (AGT), angiotensin receptor type 1 (AGTR1), and angiotensin-converting enzyme (ACE) genes and preeclampsia risk.
• To conduct a meta-analysis of studies investigating these genetic variations.

Main Methods:

• Systematic literature search of PubMed for case-control studies up to January 2006.
• Meta-analysis of polymorphisms in eNOS (Glu298Asp), AGT (Met235Thr), and ACE (intron 16 insertion-deletion) genes, including studies with >5 analyses.
• Statistical analysis using odds ratios (OR) and confidence intervals (CI) under dominant and recessive genetic models.

Main Results:

• Significant association found between AGT Met235Thr polymorphism and preeclampsia risk (OR 1.65 dominant, OR 1.54 recessive).
• Significant association found between ACE intron 16 insertion-deletion polymorphism and preeclampsia risk under the recessive model (OR 1.51).
• No single polymorphism demonstrated a major effect on preeclampsia risk.

Conclusions:

• The AGT Met235Thr and ACE intron 16 insertion-deletion polymorphisms are associated with an increased risk of preeclampsia.
• These findings contribute to understanding the genetic underpinnings of preeclampsia.
• Further research is needed to elucidate the precise mechanisms and identify major genetic contributors.